Australian Government subsidy of Continuous Glucose Monitors 23 December 2016 During the 2016 Federal Election, the Government committed to subsidise continuous glucose monitoring (CGM) technology to assist children and young adults under 21 years of age who face extra challenges managing their type 1 diabetes. The Government, through the Department of Health, is working to address this election commitment. While this work is well advanced, a commencement date has not been determined. The Department of Health is consulting with Diabetes Australia, expert endocrinologists and clinicians and other key stakeholders to assist with the implementation of this commitment as part of the National Diabetes Services Scheme (NDSS) and to ensure that eligible children and young adults receive the support they need. Work is continuing to finalise elements such as the clinical eligibility criteria, authorisation process, supply arrangements, information, education and support programs as well as the administrative and information technology systems changes required to implement this commitment. Further information will be provided once these details have been finalised.
News 27 May 2026 Urgent product correction for MiniMed Android App Medtronic and the Therapeutic Goods Administration have issued an Urgent Product Correction for a MiniMed Mobile App Android software version... Continue Reading
News 27 May 2026 Tzield listing a game-changer for early-stage type 1 diabetes The first new therapy for type 1 diabetes in nearly a century, which works to delay the need for insulin therapy in type 1 diabetes, has been approved for use in Australia by the Therapeutic Goods Administration. Continue Reading
News 27 May 2026 Important recall: Selected Omnipod® 5 and Omnipod DASH® Pods Insulet has issued a critical recall affecting specific lots of Omnipod 5 and Omnipod DASH Pods after identifying a manufacturing... Continue Reading